Bristol-Myers Squibb have recently announced the failure of the drug Opdivo® (nivolumab) to show a clinically significant effect in the treatment of small-cell lung cancer.
Approximately 1 in 4 patients being treated in the community have received DNA matched treatment from comprehensive genomic profiling results, indicating that precision medicine is now increasingly utilized in settings other than specialist hospital environments.
A personalized prediction scheme for certain chronic blood cancers has been developed, based on new disease classifications.
Adult cancer patients in England will receive the new game-changing CAR-T therapy Yescarta® under the first negotiated deal of its kind struck in Europe.
A recent systematic review has concluded that high consumption of processed meat may lead to an increased risk of developing breast cancer.
Tasuku Honjo and James P Allison have been awarded the 2018 Nobel Prize in Physiology or Medicine for their discovery of cancer therapy by inhibition of negative immune regulation.
The US FDA has approved Libtayo®, the first and only treatment specifically approved and available for advanced cutaneous squamous cell carcinoma in the USA.
Veterinary surgeons at the Ontario Veterinary College and researchers from the University of Guelph (both ON, Canada) have worked together to fit a 3D printed titanium plate for surgery on a dog’s skull, in what has been described as a ‘breakthrough’ in cancer research.
In this round up we provide you with the biggest headlines and highlights from the IASLC World Conference on Lung Cancer (WCLC) the world’s largest meeting dedicated to lung cancer and other thoracic malignancies.